What first, second, and third line mean
Treatment lines describe the sequence of regimens a patient receives. First-line therapy is the initial standard of care chosen for a given cancer type and stage. If the disease progresses or the regimen becomes intolerable, the oncologist moves to second-line therapy, then third-line, and so on. Each switch is usually triggered by evidence of progression on imaging or biomarkers, or by unacceptable toxicity.
Later lines often have lower expected response rates than first-line, partly because resistant clones have been selected by earlier treatment. This is why the choice and timing of the first regimen matters, and why clinical trials are frequently considered once standard lines are exhausted.
How a line is chosen and changed
Line selection depends on tumor type, molecular markers, prior exposure, the patient's overall condition, and what evidence supports each option. A regimen is not abandoned at the first scan fluctuation; oncologists weigh confirmed progression against the chance that a finding is transient. Maintenance therapy and treatment breaks add further nuance to the simple linear picture.
Context for this diagram
This is general educational information, not medical advice. The sequence of lines, and which drugs belong in each, differs by cancer and by region, and changes as new agents are approved. Specific treatment decisions belong with a treating oncologist.